The Root Cause Medicine Podcast
Modern Eye Care: The Gut-Eye Axis, Oculomics, HRT & More
November 20, 2025
This episode features Dr. Neda Gioia, OD, CNS®, IFMCP, a pioneer in integrative eye care who blends optometry, clinical nutrition, and functional medicine to advance preventive vision strategies. Clinicians will learn how gut-eye axis mechanisms, AI-driven oculomics, sex-hormone transitions, and nutrient patterns influence ocular inflammation, retinal biomarkers, and whole-system health. Dr. Gioia illustrates how modern imaging (including emerging AI models), stool and hormone testing, and nutrient evaluation can support earlier identification of risk patterns and more personalized, prevention-forward care for patients across the lifespan.

In this fast-moving, clinically rich tour through the new frontiers of integrative eye care, Dr. Gioia connects the dots between microbiome-driven inflammation, AI-powered retinal biomarker extraction, and hormonal transitions that reshape ocular physiology—all in a way that feels practical for everyday clinical reasoning. She illustrates how gut permeability markers may parallel ocular surface symptoms, how retinal microvascular mapping can hint at systemic resilience, and why perimenopause and menopause deserve far more attention in the modern eye exam. Throughout the episode, she gives clinicians evidence-informed frameworks for synthesizing gut, hormone, nutrient, and imaging data into a more proactive, prevention-oriented approach to vision health.


Clinical Takeaways from This Episode

Guest Introduction

Dr. Neda (Nehda) Gioia, OD, CNS®, IFMCP, FOWNS
, is the founder of Integrative Vision, where she merges optometry, functional medicine, and clinical nutrition into a prevention-first model of eye care. Drawing on her advanced training—including certification from the Institute for Functional Medicine and credentials in clinical nutrition—she educates clinicians on ocular nutrition, gut–eye interactions, and modern imaging applications. She consults nationally, offers virtual ocular nutrition services, and publishes on integrative optometry.

Labs, Nutrition, and Lifestyle Support

Clinician FAQ: Gut-Eye Axis, Oculomics, Hormones, and Preventive Eye Care

  1. How strong is the evidence linking dysbiosis to ocular inflammation? Emerging research shows meaningful associations between gut dysbiosis and ocular inflammatory pathways, including effects on cytokines, permeability, SCFA signaling, and retinal immune activation. Mechanistic animal and human data continue to expand, though large interventional trials remain limited. Citation: Rowan S, et al. Front Cell Neurosci. 2024. Available at: https://www.frontiersin.org/articles/10.3389/fncel.2024.1468187/full
  2. Which stool markers may be relevant when patients present with chronic ocular symptoms? Markers such as zonulin, calprotectin, and SCFAs may help clinicians understand permeability, gut-mediated immune activity, and microbial metabolite patterns that could interact with ocular-surface or retinal inflammatory pathways.
     Citation: Rowan S, et al. Front Cell Neurosci. 2024. Available at: https://www.frontiersin.org/articles/10.3389/fncel.2024.1468187/full
  3. How does AI-enhanced oculomics fit into preventive medicine? AI-driven retinal imaging can identify subtle microvascular changes, nerve-fiber patterns, and tissue integrity metrics that may correlate with cardiovascular, neurologic, metabolic, and longevity-related risk. These tools expand prevention by extracting systemic biomarkers from retinal data. Citation: Keane P, et al. Theranostics. 2024. Available at: https://www.thno.org/v15p3223.pdf
  4. Which hormonal shifts are most relevant to midlife changes in ocular comfort? Perimenopause- and menopause-associated fluctuations in estrogen and declines in androgen activity may impact meibomian gland lipid output, tear film stability, ocular surface sensitivity, and inflammatory thresholds.Citation: Jin, Xiuming, et al. “Hormone Replacement Therapy Benefits Meibomian Gland Dysfunction in Perimenopausal Women.” Medicine, vol. 95, no. 31, Aug. 2016, p. e4268, https://doi.org/10.1097/md.0000000000004268
  5. Should clinicians routinely evaluate eye symptoms when initiating hormone therapy? Changes in ocular comfort—including dryness, irritation, or fluctuating vision—may accompany hormone transitions or therapy adjustments. Incorporating eye-symptom questions may help clinicians detect hormone-related effects on the ocular surface. Citation: Abelson MB, Lines L. Review of Ophthalmology. 2006. Available at: https://www.reviewofophthalmology.com/article/hormones-in-dry-eye-a-delicate-balance
  6. Which nutrients are most essential for long-term ocular support? DHA, lutein, and zeaxanthin are well-studied nutrients supporting retinal function and macular pigment density. Balanced zinc and copper intake is also important for ocular and neural physiology. Citation: Age-Related Eye Disease Studies (AREDS/AREDS2): major findings https://www.nei.nih.gov/research/clinical-trials/age-related-eye-disease-studies-aredsareds2/about-areds-and-areds2 
  7. How often should adults receive a comprehensive eye exam? Dr. Gioia explains that many adults benefit from annual examinations starting around age 40—earlier or more frequently for those with ocular symptoms or systemic risk factors—because asymptomatic conditions such as early glaucoma or macular changes may be detectable only through imaging. 
  8. What’s the clinical advantage of combining gut, hormone, and retinal imaging data? According to Dr. Gioia, integrating these data streams can help clinicians observe multi-system patterns earlier—linking inflammatory load, hormonal fluctuations, nutrient availability, and microvascular integrity into a unified preventive strategy.